A weakness of whole-body PSMA-TV acquisition is that it is a time-consuming process, despite the use of algorithms for the semi-automatic quantification of tumor volume in PSMA PET/CT [10] and the use of additional neural networks [11]. The gene discussed is FOLH1; the disease is neoplasm.